Nathan Rice
Stock Analyst at Piper Sandler
(1.36)
# 1347
Out of 3,975 analysts
57
Total ratings
53.57%
Success rate
14.05%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Merchants Bancorp | Maintains: Overweight | 48 53 | 36.77 | 42.78% | 6 | Nov 26, 2024 | |
First Mid Bancshares | Maintains: Overweight | 46 47 | 36.24 | 29.69% | 3 | Nov 1, 2024 | |
Byline Bancorp | Reiterates: Overweight | 34 34 | 28.5 | 19.3% | 8 | Oct 29, 2024 | |
Bank First | Maintains: Neutral | 99 104 | 97.92 | 6.21% | 5 | Oct 17, 2024 | |
CVS Health | Maintains: Buy | 85 74 | 45.65 | 62.1% | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 84 | 103.92 | -19.17% | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 197 | 208.67 | -5.59% | 8 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 11 9 | 11.9 | -24.37% | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 40 | n/a | n/a | 1 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 530 435 | 415.28 | 4.75% | 4 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 233 | 280.46 | -16.92% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 83 | 61.61 | 34.72% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 15 | 17.7 | -15.25% | 1 | Dec 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 49 54 | n/a | n/a | 4 | Feb 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | n/a | n/a | 2 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 24, 2017 |